Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361:1329 38. 254. Tang AS, Wells GA, Talajic M, et al., Multicenter Automatic De brillator Implantation Trial Investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363: 2385 95. 255. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted de brillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933 40. Yancy et al. JACC Vol. 62, No. 16, 2013 2013 ACCF/AHA Heart Failure Guidelines: Executive Summary October 15, 2013:1495 539 256. Buxton AE, Lee KL, Fisher JD, et al., Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882 90. 257. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-de brillator after acute myocardial infarction. N Engl J Med 2004;351:2481 8. 258. Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834 43. 259. Brignole M, Gammage M, Puggioni E, et al. Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial brillation. Eur Heart J 2005;26:712 22. 260. Brignole M, Botto G, Mont L, et al. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial brillation: a randomized trial. Eur Heart J 2011;32:2420 9. 261. Doshi RN, Daoud EG, Fellows C, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005;16:1160 5. 262. Gasparini M, Auricchio A, Regoli F, et al. 